Literature DB >> 22563709

Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria.

Thierry Burnouf1, Ming-Li Chou, Yu-Wen Wu, Chen-Yao Su, Lin-Wen Lee.   

Abstract

BACKGROUND: Platelet (PLT) gels exhibit antimicrobial activity useful for wound healing. The nature of the antibacterial component(s) is unknown. STUDY DESIGN AND METHODS: PLT-poor plasma (PPP), PLT-rich plasma (PRP), PLT gel (PG), and solvent/detergent-treated PLT lysate (S/D-PL) from two donors were evaluated either native or after complement heat inactivation. Materials were spiked at a 10% ratio (vol/vol) with approximately 10(7-8) colony-forming units/mL with four Gram-positive and four Gram-negative bacteria of the wound flora. Bacterial count was determined by plate assays at time of spiking and after 3 and 48 hours at 31°C. Bacteria growth inhibition tests were also performed.
RESULTS: There was no viable Escherichia coli colony for 48 hours after spiking to the plasma and PLT materials from both donors, corresponding to greater than 7.51 to greater than 9.05 log inactivation. Pseudomonas aeruginosa, Klebsiella pneumoniae, and Staphylococcus aureus were inactivated (approx. 4.7, 7, and 2 log, respectively) 3 hours after spiking to PRP, PPP, or S/D-PL from the first donor but less (1.1, 4.6, and 0.2 log, respectively) in PG, before a regrowth at 48 hours in all materials. Similar data were obtained with the second donor. No plasma and PLT material had antimicrobial activity against Enterobacter cloacae, Bacillus cereus, Bacillus subtilis, and Staphylococcus epidermidis. Complement-inactivated samples had no antimicrobial activity.
CONCLUSION: Plasma complement is mostly responsible for the activity of plasma and PLT biomaterials against E. coli, P. aeruginosa, K. pneumoniae, and S. aureus. Activation of the coagulation to prepare PG may reduce antimicrobial activity. These findings may help optimize the control of wound infections by blood biomaterials.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22563709     DOI: 10.1111/j.1537-2995.2012.03668.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  29 in total

Review 1.  Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advances.

Authors:  Tomoyuki Kawase
Journal:  Odontology       Date:  2015-06-04       Impact factor: 2.634

2.  Preliminary evaluation of cord blood platelet gel for the treatment of skin lesions in children with dystrophic epidermolysis bullosa.

Authors:  Gianluca Tadini; Sophie Guez; Lidia Pezzani; Maurizio Marconi; Noemi Greppi; Francesca Manzoni; Paolo Rebulla; Susanna Esposito
Journal:  Blood Transfus       Date:  2014-10-29       Impact factor: 3.443

3.  Platelet-rich plasma lysate displays antibiofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro.

Authors:  Jessica M Gilbertie; Thomas P Schaer; Alicia G Schubert; Megan E Jacob; Stefano Menegatti; R Ashton Lavoie; Lauren V Schnabel
Journal:  J Orthop Res       Date:  2020-01-14       Impact factor: 3.494

Review 4.  Considerations for the use of platelet-rich plasma in orthopedics.

Authors:  Taralyn M McCarrel; Nathan A Mall; Andrew S Lee; Brian J Cole; Davietta C Butty; Lisa A Fortier
Journal:  Sports Med       Date:  2014-08       Impact factor: 11.136

5.  The efficacy of platelet-rich plasma gel in MRSA-related surgical wound infection treatment: an experimental study in an animal model.

Authors:  R A Cetinkaya; S Yilmaz; A Ünlü; P Petrone; C Marini; E Karabulut; M Urkan; E Kaya; K Karabacak; M Uyanik; I Eker; A Kilic; A Gunal
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-30       Impact factor: 3.693

6.  Epidermal growth factor vs platelet-rich plasma: Activity against chronic wound microbiota.

Authors:  Beatriz G R B de Oliveira; Fernanda P de Oliveira; Lenise A Teixeira; Geraldo R de Paula; Bianca C de Oliveira; Bruna M F B Pires
Journal:  Int Wound J       Date:  2019-10-01       Impact factor: 3.315

7.  Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix.

Authors:  Fabio Nicoli; Alberto Balzani; Davide Lazzeri; Pietro Gentile; Ram M Chilgar; Camilla Di Pasquali; Marzia Nicoli; Ilaria Bocchini; Annarita Agovino; Valerio Cervelli
Journal:  Int Wound J       Date:  2013-07-09       Impact factor: 3.315

8.  In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood.

Authors:  Jessica Intravia; Donald A Allen; Thomas Js Durant; Mary Beth R McCarthy; Ryan Russell; Knut Beitzel; Mark P Cote; Feliciano Dias; Augustus D Mazzocca
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

Review 9.  Targeting the host hemostatic system function in bacterial infection for antimicrobial therapies.

Authors:  Yuanxi Xu; Haiqing Yu; Hongmin Sun
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

10.  Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation.

Authors:  A Picardi; A S Ferraro; M Miranda; F Meconi; A Lanti; G Adorno; W Arcese; P Bollero
Journal:  Oral Implantol (Rome)       Date:  2017-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.